Vylor (NYSE:VYLR – Get Free Report) was upgraded by analysts at BNP Paribas Exane to a “hold” rating in a research report issued on Wednesday, Zacks reports.
Several other brokerages also recently weighed in on VYLR. Mizuho assumed coverage on shares of Vylor in a report on Monday, October 5th. They set an “outperform” rating and a $84.00 price target on the stock. Wolfe Research upgraded Vylor to a “strong-buy” rating in a research report on Thursday, October 1st. Royal Bank Of Canada began coverage on Vylor in a research note on Friday, October 2nd. They issued an “outperform” rating and a $85.00 price objective for the company. Wall Street Zen raised Vylor to a “sell” rating in a research note on Saturday, October 10th. Finally, Bank of America began coverage on Vylor in a research report on Monday, October 5th. They set a “buy” rating and a $78.00 target price for the company. Three analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $82.67.
View Our Latest Report on VYLR
Vylor Price Performance
Vylor Company Profile
Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.
Recommended Stories
- Five stocks we like better than Vylor
- UnitedHealth Beats on Earnings, But Investors Question Growth Path
- Swarm Economics: Can XTEND AI Robotics Deliver at Scale?
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
